Precision Testing for Drug Development

Analytical Chemistry Services
Provide precise, regulatory-compliant data to accelerate drug discovery and development. From NMR, LC-MS, and HPLC analysis to impurity profiling, stability studies, and structural confirmation, our expert team ensures your compounds meet the highest standards for safety, quality, and compliance—advancing your research with confidence and speed.

Specialized Analytical Services for Pharmaceutical Innovation

We provide a comprehensive suite of specialized analytical services tailored to the exacting standards of pharmaceutical, biotech, and chemical R&D. Our solutions cover every critical stage, from analysis and purification to separation and validation, ensuring data accuracy, regulatory compliance, and scientific excellence.

Chiral Analysis Method Development

Method development using HPLC + SFC

Scalable Chiral Separation

From milligram to kilogram scale

Prep-HPLC (UV+MS+ELSD Trigger)

High-throughput targeted compound isolation and purification

Impurity Analysis
  • Structural elucidation and quantification of impurities
  • Regulatory-compliant impurity profiling
Compound Structure Confirmation & Reporting

Definitive structural analysis using a combination of EA, HRMS, NMR, IR, and UV, with detailed reporting

Compound Solubility and Stability Determination
  • Formulation compatibility
  • Regulatory-compliant impurity profiling
oUR CAPABILITIES

Routine Analysis and Testing Services

Our routine testing and physicochemical analysis services to ensure your compounds meet exact specifications.

Technique
Capabilities
H/C/F/P/B-NMR, DEPT, HSQC, HMBC, COSY, NOESY, QNMR
DAD & ELSD detectors
Q-TOF, Orbitrap
DAD, CAD, ELSD, RID detectors
Headspace + direct injection
According to ICH guidelines
ROI, ICP-MS, IC, XRD, DVS, IR, UV, MP, optical rotation, KF, titration, heavy metal residue detection
TGA, DSC
LogP, LogD, pKa

Expertise Across Analytical Platforms

Our laboratory integrates multiple detection techniques to guarantee data integrity and method reproducibility. From preclinical compounds to commercial APIs, our team ensures your data stands up to regulatory scrutiny.

Tumor Models
Xenograft Models (186+)
Humanized Models (30+)
Syngeneic Models (30+)
Orthotopic Models (50+)
PDX Models (100+)
Non-tumor Models
CNS Diseases Models (64+)
Inflammatory & Immune Diseases (32+)
Cardiovascular Diseases (25+)
Metabolic Diseases (39+)
Digestive Diseases Models (18+)
Tumor models:

Medicilon provides a comprehensive range of oncology models, including:

  • CDX Models – Fast, reliable tumor models for early-phase drug screening.
  • PDX Models – Clinically relevant models for personalized medicine research.
 

This holistic approach ensures that researchers can seamlessly transition from early drug discovery to translational research, accelerating the path to clinical trials.

 

Applications Across Development Stages

Partner with Medicilon for reliable, high-quality analytical chemistry services

Contact Medicilon

Name
Address

Search Medicilon

【White Paper】Navigating the DMPK Gauntlet: A Strategic Analysis of the Interconnected Challenges Shaping the Future of Drug Development

Medicilon: Innovating Globally at CMC-China Expo 2025

Novamab Announces NMPA CDE Approval of IND for LQ036, the World’s First Inhaled Nanobody for Moderate-to-Severe Asthma